Variable | Number |
---|---|
IHC, immunohistochemistry. | |
Patients with IHC scores >300 (n = 25) | |
Sex | |
Male | 16 |
Female | 9 |
Age (years) | |
Range | 36–84 |
Median | 63.6 |
TNM tumour stage | |
T1 | 3 |
T2 | 6 |
T3 | 11 |
T4 | 5 |
TNM lymph node status | |
N0 | 6 |
N1 | 16 |
N2 | 3 |
Degree of differentiation | |
Well | 0 |
Moderate | 16 |
Poor | 9 |
Patients with IHC scores <150 (n = 18) | |
Sex | |
Male | 13 |
Female | 5 |
Age (years) | |
Range | 31–75 |
Median | 57.9 |
TNM tumour stage | |
T1 | 3 |
T2 | 8 |
T3 | 5 |
T4 | 2 |
TNM lymph node status | |
N0 | 15 |
N1 | 2 |
N2 | 1 |
Degree of differentiation | |
Well | 0 |
Moderate | 13 |
Poor | 5 |